Abstract:Background Cardiovascular diseases represent a significant complication arising from chronic kidney disease (CKD). Vascular calcification is an important risk factor for cardiovascular diseases. Reducing vascular calcification is therefore critical to reducing mortality in CKD patients. Hypothesis This study aims to establish a vascular calcification model in rats with CKD by administering subcutaneous injections of calcitriol in combination with a high‐calcium and high‐phosphorus diet. Methods The rats were divided into the CKD vascular calcification model group (subtotal nephrectomy+ [SNx+]) and the sham‐operated control group (subtotal nephrectomy− [SNx−]). The rats in the SNx(+) group were administered high‐calcium and high‐phosphorus feeds following a 5/6 nephrectomy. Calcitriol (1 μg/kg, three times a week) was injected subcutaneously at weeks 0, 4, 8, and 12 after the operation. Measurements of body weight, urine, serum biochemical indicators and vascular calcification level were conducted in rats. Results (1) Compared with the SNx(−) group, rats in the SNx(+) group experienced an increase in 24‐h urine output, urinary phosphorus, and urinary microprotein excretion, along with the development of severe anemia. Additionally, there was a notable elevation in serum phosphorus, blood urea nitrogen, blood creatinine, fibroblast growth factor 23 (FGF‐23), and intact parathyroid hormone levels, accompanied by severe hypoproteinemia at week 12. (2) The results of micro‐compuyed tomography (μCT) and alizarin S staining of the thoracic aorta demonstrated an increase in vascular calcification in the SNx(+) group. (3) The expression levels of vascular calcification‐related proteins were increased. Conclusions The administration of calcitriol combined with a high‐calcium and high‐phosphorus diet was found to induce vascular calcification in CKD rats, leading to a disturbance in mineral metabolism. Vascular calcification was effectively induced in CKD rats after 12 weeks of modeling, thereby presenting a novel approach for establishing a vascular calcification model in CKD rats, helping to elucidate this clinical condition and its underlying molecular mechanisms.

Intermedin(1-53) Attenuates Vascular Calcification In Rats With Chronic Kidney Disease By Upregulation Of Alpha-Klotho

Abstract 319: Intermedin Attenuates Vascular Calcification by Upregulating Klotho Via CRLR/RAMP3 Receptor Complex and Camp/pka Signaling Pathway in Rats with Chronic Kidney Disease

Intermedin Alleviates Vascular Calcification in CKD Through Sirtuin 3-Mediated Inhibition of Mitochondrial Oxidative Stress

Intermedin inhibits vascular calcification by increasing the level of matrix gamma-carboxyglutamic acid protein

Intermedin1-53 attenuates vascular smooth muscle cell calcification by inhibiting endoplasmic reticulum stress via cyclic adenosine monophosphate/protein kinase A pathway

in rats with chronic kidney disease by Intermedin 1 – 53 attenuates vascular calci fi cation upregulation of a-Klotho

INTERMEDIN1-53 AMELIORATES HOMOCYSTEINE-PROMOTED ATHEROSCLEROTIC CALCIFICATION BY INHIBITING ENDOPLASMIC RETICULUM STRESS

Intermedin1-53 attenuates aging-associated vascular calcification in rats by upregulating sirtuin 1

Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase

Intermedin alleviates diabetic vascular calcification by inhibiting GLUT1 through activation of the cAMP/PKA signaling pathway

Intermedin1–53 inhibits rat cardiac fibroblast activation induced by angiotensin II

Indoxyl Sulfate Enhance the Hypermethylation of Klotho and Promote the Process of Vascular Calcification in Chronic Kidney Disease.

Calcitriol combined with high‐calcium and high‐phosphorus diet induces vascular calcification model in chronic kidney disease rats

Intermedin alleviates pathological cardiac remodeling by upregulating klotho

Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway

Effects of intermedin1-53 on myocardial fibrosis

Peroxisome Proliferator-Activated Receptor-γ Coactivator-1α Inhibits Vascular Calcification Through Sirtuin 3-Mediated Reduction of Mitochondrial Oxidative Stress.

Intermedin 1-53 Inhibits Myocardial Fibrosis in Rats by Down-Regulating Transforming Growth Factor-β

Adrenomedullin(27–52) Inhibits Vascular Calcification in Rats

Mammalian target of rapamycin signaling inhibition ameliorates vascular calcification via Klotho upregulation

Overexpression of miR-204-5p Alleviates Osteogenic Differentiation and Calcification of Human Aortic Vascular Smooth Muscle Cells by Targeting Calcium/Calmodulin-dependent Protein Kinase 1